←
Sofiya Hupalo1,168 posts
Sofiya Hupalo avatar

Sofiya Hupalo

@sofiyahupalo

Neuroscientist interested in supporting mental health research & early career scientists. Views/tweets ≠ endorsement

◷ Joined February 2013▧ 50 Photos and videos
NPP-Digital Psychiatry and Neuroscience (DPN) avatar
⟳ Sofiya Hupalo retweeted
NPP-Digital Psychiatry and Neuroscience (DPN)@dpn_journal·Sep 18

Clinical trials in psychiatry rely on measures of symptomatology, not biology. This @ACNPorg position paper lays out why validated biomarkers in psychiatry have lagged behind fields like Alzheimer's and ALS, and what it will take to close the gap: precompetitive data sharing, standardized protocols, & earlier FDA engagement. nature.com/articles/s44277-0…

NPP-Digital Psychiatry and Neuroscience (DPN) avatar
⟳ Sofiya Hupalo retweeted
NPP-Digital Psychiatry and Neuroscience (DPN)@dpn_journal·May 11

One week left to apply for our Editors’ New Investigator Award ⬇️⬇️⬇️ nature.com/dpn/announcements…

📢 We’re excited to announce the next call for applications for the DPN Editors' New Investigator Award! This award waives the article processing charge ($2290) for new investigators who aim to publish an original report in DPN. Apply by May 18th! nature.com/dpn/announcements…

Post attachment
Psychedelic Alpha avatar
⟳ Sofiya Hupalo retweeted
Psychedelic Alpha@Psyched_Alpha·Apr 18

BREAKING: President Trump Signs Executive Order to Accelerate Psychedelic Research and Access This is a breaking story. More to follow.

Post attachment
NPP-Digital Psychiatry and Neuroscience (DPN) avatar
⟳ Sofiya Hupalo retweeted
NPP-Digital Psychiatry and Neuroscience (DPN)@dpn_journal·Mar 26

Learn more about the recent cohort of recipients of DPN's New Investigator Award, and apply by May 18th!

📢 We’re excited to announce the next call for applications for the DPN Editors' New Investigator Award! This award waives the article processing charge ($2290) for new investigators who aim to publish an original report in DPN. Apply by May 18th! nature.com/dpn/announcements…

Post attachment
Sofiya Hupalo avatar
Sofiya Hupalo@sofiyahupalo·Mar 3

Very cool structural biology and molecular pharmacology study on psychedelic mechanisms of action. But, I cringe at references to hallucinations in mice, even with qualifiers about limitations of animal models. We need to be more precise in our descriptions of animal behavior!

🚨 The NO TRIP mushroom for depression We finally know how psychedelics cause hallucinations vs. therapeutic effects at the 5-HT2A receptor. Gi signaling drives the trip, Gq drives the relief. And they just designed a non-hallucinogenic analog to prove it 🧵

Post attachment
Jared Saletin avatar
⟳ Sofiya Hupalo retweeted
Jared Saletin@JSaletin·Feb 18

The sleeping brain influences the waking mind. This was a fun one. A brief one-stop shop to sleep theory, measurement, and interpretation, with a focus on the EEG and its relevance to psychiatric research. Hope it's useful! @BrownPsychiatry @BradleyHospital

Check out our 🆕 Primer which walks through the neuroscience of sleep, how sleep is measured, key EEG features, and why it's important to assess sleep dysregulation in psychiatric care and research. By @JSaletin & Giulia Righi nature.com/articles/s44277-0…

NPP-Digital Psychiatry and Neuroscience (DPN) avatar
⟳ Sofiya Hupalo retweeted
NPP-Digital Psychiatry and Neuroscience (DPN)@dpn_journal·Feb 4

Recapping the #ACNP2026 study group, “Centering Lived Experience in Psychiatric Neuroscience Research” We asked the panelists, what could NIH leadership do to be more supportive of trainees with non-traditional career paths, which is common among researchers with lived experience of mental illness?

2:00
Al Kaye avatar
⟳ Sofiya Hupalo retweeted
Al Kaye@akaye·Jan 26

We're interested in hiring a post-baccalaureate research associate to work in circuit and systems neuroscience studies of anxiety. Please reach out - my email is listed at kayelab.com - if interested or share with undergraduate/recent grads who may be interested.

Post attachment
Neuropsychopharmacology avatar
⟳ Sofiya Hupalo retweeted
Neuropsychopharmacology@npp_journal·Jan 22

Recent US data shows overdose deaths involving both synthetic opioids & stimulants rose from 2018 until 2023, then declined sharply in 2024, driven by decreases in opioid-involved deaths. Despite recent declines, polydrug overdose mortality remains high nature.com/articles/s41386-0…